Press releasePRNewswire
Collplant Biotechnologies
CLGN · NASDAQ
$3.88+$0.00 (+0.00%)TodayMarket closed ·
Prev close $3.88
Latest news
- Press releasePRNewswire
LightSolver Files U.S. Provisional Patent Application Expanding its Photonic Computing Platform to Advanced Scientific and Engineering Simulations
- Press releasePRNewswire
COLLPLANT REPORTS 2026 SECOND QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
- Press releasePRNewswire
LightSolver, a CollPlant Company, and HLRS Joint Research Demonstrated Photonic Computing Can significantly Accelerate Fundamental HPC Workloads
- Press releasePRNewswire
CollPlant Regains Compliance with Nasdaq Minimum Bid Price Requirement
- Press releasePRNewswire
CollPlant to Host LightSolver Investor Webinar on September 17, 2026
- Press releasePRNewswire
COLLPLANT APPOINTS DR. RUTI BEN SHLOMI TO ITS BOARD OF DIRECTORS FOLLOWING CLOSING OF LIGHTSOLVER ACQUISITION
- Press releasePRNewswire
COLLPLANT COMPLETES ACQUISITION OF LIGHTSOLVER, ENTERING THE PHOTONIC COMPUTING SECTOR
- Press releasePRNewswire
COLLPLANT ANNOUNCES REVERSE SHARE SPLIT
- NewsAvi Kapoor
Why Pyxis Tankers Shares Are Trading Higher By Over 11%; Here Are 20 Stocks Moving Premarket
- NewsAvi Kapoor
Crude Oil Gains Over 2%; US Dallas Fed Manufacturing Index Surges In August
- NewsAvi Kapoor
Dow Falls Over 300 Points; SAIC Shares Jump After Upbeat Q2 Results
- Press releasePRNewswire
COLLPLANT IS ACQUIRING LIGHTSOLVER- ENTERS SUPERCOMPUTING AND PHOTONIC COMPUTING MARKETS
- Press releasePRNewswire
COLLPLANT BIOTECHNOLOGIES ANNOUNCES $2.6 MILLION PRIVATE PLACEMENT
- News
12 Health Care Stocks Moving In Friday's After-Market Session
- NewsCaroline Ryan
Deal Dispatch: Fertitta Entertainment Buys Caesars For $17.6 Billion, Arsenal Capital Buys Velcro Brands, Teaneck Surgical Center Bankruptcy
- Press releasePRNewswire
COLLPLANT BIOTECHNOLOGIES REPORTS 2026 FIRST QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
- News
12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- News
12 Health Care Stocks Moving In Thursday's Intraday Session
- Press releasePRNewswire
CollPlant Issues Letter to Shareholders
- Press releasePRNewswire
COLLPLANT BIOTECHNOLOGIES REPORTS 2025 FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
- News
Earnings Scheduled For March 26, 2026
- Press releasePRNewswire
CollPlant Biotechnologies Receives Nasdaq Notification Regarding Minimum Bid Requirement
- News
12 Health Care Stocks Moving In Tuesday's Intraday Session
- Press releasePRNewswire
CollPlant Biotechnologies Launches Redesigned Corporate Website
- Press releasePRNewswire
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR FULL YEAR 2025 FINANCIAL RESULTS
- News
12 Health Care Stocks Moving In Thursday's After-Market Session
- Press releasePRNewswire
CollPlant Biotechnologies Announces Korean Patent Allowance Secured for its Photocurable Dermal Filler
- Press releasePRNewswire
CollPlant Elevates rhCollagen 3D Bioprinting Portfolio with Launch of Ready-to-Print BioFlex
- Press releasePRNewswire
CollPlant Targets New Aesthetic Market Driven by GLP-1 Weight-Loss Treatments
- News
12 Health Care Stocks Moving In Tuesday's Pre-Market Session
- News
12 Health Care Stocks Moving In Thursday's Intraday Session
- Press releasePRNewswire
COLLPLANT BIOTECHNOLOGIES ANNOUNCES $2.0 MILLION REGISTERED DIRECT OFFERING
- Press releasePRNewswire
COLLPLANT BIOTECHNOLOGIES REPORTS 2025 THIRD QUARTER FINANCIAL RESULTS AND PROVIDES CORPORATE UPDATE
- Press releasePRNewswire
COLLPLANT BIOTECHNOLOGIES ANNOUNCES DATE FOR 2025 THIRD QUARTER FINANCIAL RESULTS
Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.